ISCTM 9th Annual Scientific Meeting

By Cheryl Selleny, Marketing & Communications

The ISCTM 9th Annual Scientific Meeting took place in Washington, D.C on 19 – 21 February. The International Society for CNS Clinical Trials and Methodology (ISCTM) is a multi-disciplinary independent organization, devoted to promoting advances that address strategic clinical, regulatory, methodological and policy challenges that arise in the development and use of CNS therapeutic agents.

The Annual Meeting provided an impressive agenda addressing the methodological and regulatory issues that confound CNS drug development. Bracket’s Adam Butler chaired the session, Suicidal Ideation and Behavior: Methodological and Technical Challenges, along with Michelle Stewart, PhD and Roger Meyer, MD. The symposium tackled such topics as the Use of the C-SSRS in Clinical Trials: Predicting Short-Term Risk and Detecting Clinical Change and Methodological Approach to the Use and Interpretation of Baseline History of Suicidal Ideation and Behavior.

Bracket Subject Matter Experts presented a total of four scientific posters at the Meeting as well:

Assessing Cognitive Function Via The Internet 
Presented by Keith A. Wesnes, PhD

Clinical Trials in Which The CDR System Has Been Employed to Detect Enhancements in Cognitive Function
Presented by Keith A. Wesnes, PhD

How Do US Sites Compare with Rest of World in PANSS Interview and Ratings Quality
Presented by David G.Daniel, MD and Alan Kott, MD

Could A Simplified PANSS Be More Efficient (no longer available)
Presented by Gary Sachs, MD